Zogenix

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Zogenix and buy or sell other stocks, ETFs, and their options commission-free!

About ZGNX

Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. 

CEO
Iris Löw-Friedrich, MD, PhD
CEOIris Löw-Friedrich, MD, PhD
Employees
Employees
Headquarters
Emeryville, California
HeadquartersEmeryville, California
Founded
2006
Founded2006
Employees
Employees

ZGNX Key Statistics

Market cap
1.50B
Market cap1.50B
Price-Earnings ratio
-6.55
Price-Earnings ratio-6.55
Dividend yield
Dividend yield
Average volume
3.46M
Average volume3.46M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$26.90
52 Week high$26.90
52 Week low
$11.03
52 Week low$11.03

Stock Snapshot

As of today, Zogenix(ZGNX) shares are valued at $26.68. The company's market cap stands at 1.5B, with a P/E ratio of -6.55.

During the trading day, Zogenix(ZGNX) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 3.46M.

The stock's 52-week range extends from a low of $11.03 to a high of $26.90.

The stock's 52-week range extends from a low of $11.03 to a high of $26.90.

People also own

Based on the portfolios of people who own ZGNX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.